News
CNS involvement doesn’t affect survival after allo-SCT
By analyzing transplant outcomes in more than 5000 patients, researchers found that subjects with CNS AML had rates of relapse and survival that...
News
Bacteria may protect against GVHD-related mortality
Experiments showed that Blautia, commensal bacteria found in the intestinal tract, can protect against GVHD-related mortality in mice and in...
News
TNC dose can affect PFS, OS after PBSCT
Researchers found that a higher TNC dose was associated with better progression-free survival (PFS) and overall survival (OS) among patients who...
News
Allo-SCT can be effective in advanced SS, MF
Allogeneic stem cell transplant (SCT) proved particularly effective in patients with Sézary syndrome (SS). It also conferred benefits to mycosis...
News
Consortium study falls short of expectations
The North American PTCL Consortium set out to find a treatment that could best CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine, and...
News
Regimen shows promise for ENKTL
The combination of pegaspargase, gemcitabine, and oxaliplatin (P-Gemox) elicited a high rate of response in this cohort of 60 Chinese patients. P...
News
TNFRII may play key role in CTCL, speaker says
The team discovered that a mutation in this receptor—TNFRII T377I—is present in patients with mycosis fungoides (MF) and those with Sézary...
News
Inhibitor appears active in relapsed/refractory TCLs
Among 26 evaluable patients, 9 experienced partial responses to treatment with IPI-145, and 1 achieved a complete response, for an overall...
News
A new prognostic model for PTCL?
Researchers analyzed nearly 9000 patients diagnosed with PTCL in the US and found evidence to suggest that patient age and race, as well as...
News
Is the US running too many T-cell lymphoma trials?
SAN FRANCISCO—The US currently has 284 open clinical trials enrolling patients with T-cell lymphomas, a fact that is actually detrimental to this...
